Parecoxib Sodium API

Name	Parecoxib sodium
Chinese name	帕瑞昔布钠
Cas Number	198470-85-8
Source	India
Qualifications	USDMF/-/-/-/-

""Parecoxib sodium was jointly developed by Pfizer and Pharmacia. It was first listed in Europe in 2002. It has been listed in at least 15 countries including Germany, France, and the United Kingdom; it was approved for listing in China in 2008. Parecoxib sodium belongs to Non-steroidal anti-inflammatory drugs are the world's first selective cyclooxygenase-2 inhibitors that can be injected intravenously and intramuscularly at the same time. Compared with traditional non-selective cyclooxygenase inhibitors, it has better analgesic effects , Fast onset, long-lasting effect, can effectively inhibit hyperalgesia, high gastrointestinal safety, does not affect platelet function, and does not increase cardiovascular risk. Parecoxib sodium has been recommended by authoritative clinical guidelines in various countries and is widely used in the short-term treatment of postoperative pain in many departments such as orthopedics, general surgery, hepatobiliary surgery, urology, thoracic surgery, obstetrics and gynecology. ""

Hot Tags: parecoxib sodium api, China, suppliers, manufacturers, factory, customized, price, pricelist, in stock, Troxagliptin Succinate API, Escitalopram Oxalate API, Fondaparinux API, Active Pharmaceutical Ingredient, Tippyridine Hydrochloride API, Ranolazine API

• Previous: Procapride API
• Next: Ferrous Sulfate API